About

Lokman Hekim

Founded in 2022 in Istanbul, Turkey, Lokman Hekim distills 18 years of cumulative senior-team expertise into a single, fully integrated CDMO. Our strength lies in a multidisciplinary technical core that has already designed, synthesized and formulated molecules now progressing through global clinical pipelines.

home

We Employ Latest Research Technology & Company

Committed to solving complex challenges, we empower industries with cutting-edge science and engineering for a better, more sustainable future.  

Why Choose Lukman Hakim

End-to-End CDMO Solutions

From custom synthesis and formulation to GMP manufacturing and regulatory support, we cover the entire pharmaceutical development cycle under one roof.

Regulatory Excellence

Our QA and regulatory teams include former agency reviewers and QPs, ensuring compliance with FDA, EMA, TGA, and PMDA standards.

Proven Technical Expertise

Multidisciplinary PhD-level chemists, engineers, and pharmacists with 18+ years of experience driving molecules into global clinical

Global Reliability & Value

Competitive pricing, transparent processes, and dependable delivery make us a trusted partner for international pharma companies.

What this means for you

home

Why Partner with Lokman Hekim Pharma?

Collaborative Innovation: Work alongside our expert scientists and engineers to bring your pharmaceutical products to life, from early-stage development to commercial-scale manufacturing.

Global Expertise: Leverage our deep regulatory knowledge and global experience to navigate the complexities of international pharmaceutical markets and ensure compliance with the highest standards.

Shaping the Future of Pharma with Innovation, Integrity, and Sustainability

Collaboration with us is more than improving resource utilization; it’s about shaping a future rooted in sustainability and efficiency. Let’s work together to pioneer new pathways in resource management and elevate industrial performance.

Contact us

how we may help you!

Blogs & News

Explore Blogs & News